Trends in the incidence and mortality of coronary heart disease in Asian pacific region - The Singapore experience

Journal of Atherosclerosis and Thrombosis

Volumn 21, Issue SUPPL. 1, 2014, Pages

  Khoo, Chin Meng ^a,c   Tai, E Shyong ^a,b,c  

^a Dept Medicine Endocrinol Diabet   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c DUKE NUS MEDICAL SCHOOL   (Singapore)

Author keywords

Coronary heart disease; Risk factors; Singapore

Indexed keywords

ANTIHYPERTENSIVE AGENT; C REACTIVE PROTEIN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ROSUVASTATIN;

ARTICLE; ASIAN; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CLINICAL TRIAL (TOPIC); DIABETES MELLITUS; DIETARY INTAKE; DISEASE CONTROL; ETHNIC DIFFERENCE; ETHNICITY; GENETIC ASSOCIATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INFLAMMATION; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; LIFESTYLE MODIFICATION; MALNUTRITION; MORBIDITY; OBESITY; PHYSICAL ACTIVITY; SINGAPORE;

ADIPOSITY; CORONARY DISEASE; ETHNIC GROUPS; HUMANS; INCIDENCE; LIFE STYLE; NUTRITIONAL STATUS; RISK FACTORS; SINGAPORE;

EID: 84893033336     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, et al: Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation, 2011; 123: e18-e209
2. British Heart Foundation Statistics Database. Coronary heart disease statistics, 2010. www.heartstats.org (accessed 26 February 2013)
3. Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M, et al: European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J, 2012; 33: 1635-1701
4. Unal B, Critchley JA, Capewell S: Modelling the decline in coronary heart disease deaths in England and Wales, 1981-2000: comparing contributions from primary prevention and secondary prevention. BMJ, 2005; 331: 614
5. Mackenbach J P, Bos V, Andersen O, Cardano M, Costa G, Harding S, et al: Widening socioeconomic inequalities in mortality in six Western European countries. Int J Epidemiol, 2003; 32: 830-837
6. Singapore world's most affluent by GDP per capita. http://business.asiaone.com (accessed 26 February 2013)
7. Khoo KL, Tan H, Liew YM, Deslypere J P, Janus E: Lipids and coronary heart disease in Asia. Atherosclerosis, 2003; 169: 1-10
8. Mak KH, Chia KS, Kark JD, Chua T, Tan C, Foong BH, et al: Ethnic differences in acute myocardial infarction in Singapore. Eur Heart J, 2003; 24: 151-160
9. MOH. Singapore Health Facts. www.moh.gov.sg (accessed 26 February 2013)
10. Ueshima H, Sekikawa A, Miura K, Turin TC, Takashima N, Kita Y, et al: Cardiovascular disease and risk factors in Asia: a selected review. Circulation, 2008; 118: 2702-2709
11. Dwyer T, Emmanuel SC, Janus ED, Wu Z, Hynes KL, Zhang C: The emergence of coronary heart disease in populations of Chinese descent. Atherosclerosis, 2003; 167: 303-310
12. Yusuf S, Reddy S, Ounpuu S, Anand S: Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation, 2001; 104: 2746-2753
13. Gupta R, Gupta VP: Meta-analysis of coronary heart disease prevalence in India. Indian Heart J, 1996; 48: 241-245
14. Deb S, Dasgupta A: A study on risk factors of cardiovascular diseases in an urban health center of kolkata. Indian J Community Med, 2008; 33: 271-275
15. Mandal S, Saha JB, Mandal SC, Bhattacharya RN, Chakraborty M, Pal PP: Prevalence of ischemic heart disease among urban population of siliguri, west bengal. Indian J Community Med, 2009; 34: 19-23
16. Leeder, S., S. Raymond, H. Greenberg, H. Liu, and K. Esson: A Race against Time: The Challenge of Cardiovascular Disease in Developing Countries. New York: Trustees of Columbia University, 2004
17. Zhang XH, Lu ZL, Liu L: Coronary heart disease in China. Heart, 2008; 94: 1126-1131
18. Births and Deaths. http://www.singstat.gov.sg (accessed 26 February 2013)
19. National Nutrition Survey 2004. www.hpb.gov.sg (accessed 26 February 2013)
20. Aim For 150 Minutes Of Physical Activity Every Week. http://www.hpb.gov.sg (accessed 26 February 2013)
21. Khaing Nang EE, Khoo EY, Salim A, Tai ES, Lee J, Van Dam RM: Patterns of physical activity in different domains and implications for intervention in a multi-ethnic Asian population: a cross-sectional study. BMC Public Health, 2010; 10: 644
22. National Health Survey 2004. http://www.hpb.gov.sg (accessed 26 February 2013)
23. Tai ES, Ordovas JM: Genome-wide association studies for blood lipids. A great start but a long way to go. Curr Opin Lipidol, 2010; 21: 101-103
24. Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy RM, Lindgren CM, et al: A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science, 2007; 316: 889-894
25. Andreasen CH, Stender-Petersen KL, Mogensen MS, Torekov SS, Wegner L, Andersen G, et al: Low physical activity accentuates the effect of the FTO rs9939609 polymorphism on body fat accumulation. Diabetes, 2008; 57: 95-101
26. Kilpelainen TO, Qi L, Brage S, Sharp SJ, Sonestedt E, Demerath E, et al: Physical activity attenuates the influence of FTO variants on obesity risk: a meta-analysis of 218,166 adults and 19,268 children. PLoS Med, 2011; 8: e1001116
27. Wu Y, Tai ES, Heng D, Tan CE, Low L P, Lee J: Risk factors associated with hypertension awareness, treatment, and control in a multi-ethnic Asian population. J Hyper-tens, 2009; 27: 190-197
28. Khoo CM, Tan ML, Wu Y, Wai DC, Subramaniam T, Tai ES and Lee J: Prevalence and control of hypercholesterol-aemia as defined by NCEP-ATPIII guidelines and predictors of LDL-C goal attainment in a multi-ethnic Asian population. Ann Acad Med Singapore, 2013; 42: 379-387
29. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM, Jr., Kastelein JJ, et al: Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med, 2008; 359: 2195-2207
30. Khoo CM, Tan M, Wu Y, Wai CH, Subramaniam T, Lee J, et al: Central obesity and smoking are key modifiable risk factors for elevated C-reactive protein in Asian individuals who are not eligible for statin therapy. Nutr Diabetes, 2011; 1: e8
31. More heart attacks but fewer deaths. http://www.yourhealth.com.sg (accessed 26 February 2013)
32. Venketasubramanian N, Tan LC, Sahadevan S, Chin JJ, Krishnamoorthy ES, Hong CY, et al: Prevalence of stroke among Chinese, Malay, and Indian Singaporeans: a community-based tri-racial cross-sectional survey. Stroke, 2005; 36: 551-556
33. Yeo KK, Tai BC, Heng D, Lee JM, Ma S, Hughes K, et al: Ethnicity modifies the association between diabetes mellitus and ischaemic heart disease in Chinese, Malays and Asian Indians living in Singapore. Diabetologia, 2006; 49: 2866-2873
34. Ang LW, Ma S, Cutter J, Chew SK, Tan CE, Tai ES: The metabolic syndrome in Chinese, Malays and Asian Indians. Factor analysis of data from the 1998 Singapore National Health Survey. Diabetes Res Clin Pract, 2005; 67: 53-62
35. Lear SA, Humphries KH, Kohli S, Chockalingam A, Frohlich JJ, Birmingham CL: Visceral adipose tissue accumulation differs according to ethnic background: results of the Multicultural Community Health Assessment Trial (M-CHAT). Am J Clin Nutr, 2007; 86: 353-359
36. Liew CF, Seah ES, Yeo K P, Lee KO, Wise SD: Lean, non-diabetic Asian Indians have decreased insulin sensitivity and insulin clearance, and raised leptin compared to Caucasians and Chinese subjects. Int J Obes Relat Metab Dis-ord, 2003; 27: 784-789
37. Alberti KG, Zimmet P, Shaw J: The metabolic syndrome--a new worldwide definition. Lancet, 2005; 366: 1059-1062
38. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al: Diagnosis and management of the metabolic syndrome: an American Heart Association/ National Heart, Lung, and Blood Institute Scientific Statement. Circulation, 2005; 112: 2735-2752
39. Khoo CM, Liew CF, Chew SK, Tai ES: The impact of central obesity as a prerequisite for the diagnosis of metabolic syndrome. Obesity (Silver Spring), 2007; 15: 262-269
40. Lee J, Ma S, Heng D, Tan CE, Chew SK, Hughes K, et al: Should central obesity be an optional or essential component of the metabolic syndrome? Ischemic heart disease risk in the Singapore Cardiovascular Cohort Study. Diabetes Care, 2007; 30: 343-347
41. Khoo CM, Sairazi S, Taslim S, Gardner D, Wu Y, Lee J, et al: Ethnicity modifies the relationships of insulin resistance, inflammation, and adiponectin with obesity in a multiethnic Asian population. Diabetes Care, 2011; 34: 1120-1126